Advanced Filters
noise

Preeclampsia Clinical Trials

A listing of Preeclampsia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 115 clinical trials
A Ayesha Bryant, MD, MSPH

Exosome Cargo From Preeclampsia Patients

Although extensively studied, the cause of preeclampsia remains uncertain other than it is thought that the placenta plays a critical role in the development of preeclampsia. Recent data revealed that exosomes released from the placenta could cause preeclampsia by transporting specific cargo responsible for the pathophysiological changes associated with the …

18 - 45 years of age Female Phase N/A
Y Yousra O Mokhtar

Fetal Renal Artery Doppler in Patients With Preeclampsia

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

years of age Female Phase N/A
S Silvia Giugliano, PhD

Role of the Maternal Microbiota on the Immune Response and Metabolism During Hypertensive Disorders

Preeclampsia (PE) is a significant cause of maternal and fetal morbidity and mortality, characterized by high blood pressure and proteinuria during pregnancy. It has two main phenotypes: one linked to placental damage and the other to metabolic factors like obesity. Early identification of high-risk groups is crucial, though there's ongoing …

18 years of age Female Phase N/A
S Sherif Ashoush, MD

Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia

The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. …

18 years of age Female Phase N/A
C Catalina De Paco Matalllana, MD

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to …

18 years of age Female Phase N/A
C Chiara Agostinis, BSc

Role of Anti-C1q Autoantibodies in Pregnancy

Preeclampsia (PE) is a very frequent obstetric complication. C1q, the first recognition molecule of the classical pathway of complement system (C), represents a double-edged molecule in determining pregnancy outcomes. In animal models, C1q deficiency caused the development of a dysfunctional placenta and PE-like symptoms. Conversely, lower levels of C components …

18 years of age Female Phase N/A

Cardiac Biomarkers in Preeclampsia: Prediction of Disease and the Risk of Future Cardiovascular Events in Survivors

SUMMARY Background: Improvements in the management and prevention of obstetric haemorrhage and sepsis, in addition to magnesium sulphate for preeclampsia have led to significant reduction in global maternal mortality rates; thus leaving increasing number of survivors of preeclampsia than previously. Preeclampsia is associated with inflammatory changes that alter vascular integrity …

18 - 45 years of age Female Phase N/A
S Suchita Nadkarni

Aspirin and Neutrophils in Preeclampsia

The exact mechanisms by which aspirin prevents the development of preeclampsia in high-risk patients are currently not fully known. Furthermore, a small proportion of high-risk patients who are on low-dose aspirin (LDA) still go on to develop preeclampsia (PE). This longitudinal observational study will assess the immune profile in participants …

18 years of age Female Phase N/A
N Nizar Amllah, M.D

Analysis of Biological Progression and Regression of HELLP Syndrome in Time

Prospective observational study about progression and regression of biological parameters of HELLP syndrome

years of age Female Phase N/A
J Joanna Suliburska, Professor

Dietary Salicylates and Preeclampsia

Preeclampsia (PE) is an important pregnancy complication and cause of maternal and perinatal mortality and morbidity. The underlying etiology and pathophysiology of preeclampsia is incompletely understood but it involves dysfunctional cytotrophoblastic invasion, placental ischemia, and release of inflammatory and endothelial mediators. Placenta dysfunction in PE is related to angiogenic balance. …

18 - 45 years of age Female Phase N/A

Simplify language using AI